BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21798075)

  • 21. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
    Shen R; Xu PP; Wang N; Yi HM; Dong L; Fu D; Huang JY; Huang HY; Janin A; Cheng S; Wang L; Zhao WL
    Clin Transl Med; 2020 Nov; 10(7):e221. PubMed ID: 33252851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of primary small intestinal lymphoma: a retrospective study based on double balloon endoscopy.
    Li L; Ma H; Niu M; Chen C; Yu C; Zhang H; Jin M
    BMC Gastroenterol; 2024 Mar; 24(1):116. PubMed ID: 38504190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort.
    Mezger NCS; Hämmerl L; Griesel M; Seraphin TP; Joko-Fru YW; Feuchtner J; Zietsman A; Péko JF; Tadesse F; Buziba NG; Wabinga H; Nyanchama M; Chokunonga E; Kéita M; N'da G; Lorenzoni CF; Akele-Akpo MT; Mezger JM; Binder M; Liu B; Bauer M; Henke O; Jemal A; Kantelhardt EJ
    Oncologist; 2023 Nov; 28(11):e1017-e1030. PubMed ID: 37368350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
    Bhansali RS; Barta SK
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
    Diez-Feijóo R; Andrade-Campos M; Gibert J; Sánchez-González B; Fernández-Ibarrondo L; Fernández-Rodríguez C; Garcia-Gisbert N; Camacho L; Lafuente M; Vázquez I; Colomo L; Salar A; Bellosillo B
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stable use of radiotherapy in lymphoma patients over time - A comprehensive national overview of radiotherapy use in Sweden with focus on older patients.
    Glimelius I; Ekberg S; Ekström Smedby K; Wästerlid T
    Clin Transl Radiat Oncol; 2024 May; 46():100785. PubMed ID: 38694236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis.
    Modemann F; Ahmadi P; von Kroge PH; Weidemann S; Bokemeyer C; Dierlamm J; Fiedler W; Ghandili S
    Leuk Lymphoma; 2023; 64(11):1801-1810. PubMed ID: 37552203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons.
    Pearse WB; Reid EG
    Surg Oncol Clin N Am; 2024 Apr; 33(2):447-466. PubMed ID: 38401918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Hodgkin Lymphoma of the jejunum presenting as perforation peritonitis: A case report.
    Warsinggih ; Darmadi S; Prihantono ; Faruk M
    Ann Med Surg (Lond); 2020 Jul; 55():131-134. PubMed ID: 32477511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal Ileitis Caused by Diffuse Large B-Cell Lymphoma in an Elderly Patient From Honduras.
    Newman J; Hong A; Zhang J; Dabash A; Gehring J; Lynn L; Borum M; Bhattacharya S
    ACG Case Rep J; 2024 Jun; 11(6):e01356. PubMed ID: 38883579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A composite lymphoma combining a Hodgkin lymphoma and a marginal zone lymphoma transformed into a diffuse large B-cell lymphoma.
    Auditeau C; Lambotte O; Feriel J; Lazure T; Turhan A; Aumont C
    Clin Case Rep; 2018 Dec; 6(12):2341-2346. PubMed ID: 30564326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound manifestations of primary intestinal non-Hodgkin lymphoma with liver metastasis in a child.
    Wang XY; Zhu YT; Zheng S; Xiao F; Zhu YY; Che S; Hu P
    J Clin Ultrasound; 2024 Jun; ():. PubMed ID: 38840562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults.
    Kendel NE; Stanek JR; Willen FK; Audino AN
    Pediatr Hematol Oncol; 2024 Apr; ():1-10. PubMed ID: 38587477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erratum: The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
    J Clin Oncol; 2024 Mar; 42(7):862. PubMed ID: 38207253
    [No Abstract]   [Full Text] [Related]  

  • 35. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.
    Tse E; Gill H; Loong F; Kim SJ; Ng SB; Tang T; Ko YH; Chng WJ; Lim ST; Kim WS; Kwong YL
    Am J Hematol; 2012 Jul; 87(7):663-8. PubMed ID: 22641357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.
    Chan JK; Chan AC; Cheuk W; Wan SK; Lee WK; Lui YH; Chan WK
    Am J Surg Pathol; 2011 Oct; 35(10):1557-69. PubMed ID: 21921780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and endoscopic features of primary small bowel lymphoma: a single-center experience from mainland China.
    Tian FY; Wang JX; Huang G; An W; Ai LS; Wang S; Wang PZ; Yu YB; Zuo XL; Li YQ
    Front Oncol; 2023; 13():1142133. PubMed ID: 37397371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
    Veloza L; Cavalieri D; Missiaglia E; Ledoux-Pilon A; Bisig B; Pereira B; Bonnet C; Poullot E; Quintanilla-Martinez L; Dubois R; Llamas-Gutierrez F; Bossard C; De Wind R; Drieux F; Fontaine J; Parrens M; Sandrini J; Fataccioli V; Delfau-Larue MH; Daniel A; Lhomme F; Clément-Filliatre L; Lemonnier F; Cairoli A; Morel P; Glaisner S; Joly B; El Yamani A; Laribi K; Bachy E; Siebert R; Vallois D; Gaulard P; Tournilhac O; De Leval L
    Haematologica; 2023 Jan; 108(1):181-195. PubMed ID: 35708139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
    Yi JH; Lee GW; Do YR; Jung HR; Hong JY; Yoon DH; Suh C; Choi YS; Yi SY; Sohn BS; Kim BS; Oh SY; Park J; Jo JC; Lee SS; Oh YH; Kim SJ; Kim WS
    Ann Hematol; 2019 Nov; 98(11):2541-2550. PubMed ID: 31493002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype.
    Tan SY; Chuang SS; Tang T; Tan L; Ko YH; Chuah KL; Ng SB; Chng WJ; Gatter K; Loong F; Liu YH; Hosking P; Cheah PL; Teh BT; Tay K; Koh M; Lim ST
    Leukemia; 2013 Aug; 27(8):1688-96. PubMed ID: 23399895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.